Amylyx Pharmaceuticals Revenue and Competitors

Claim your profile

Boston, MA USA



Growjo Ranking



Estimated Revenue & Valuation

  • Amylyx Pharmaceuticals's estimated annual revenue is currently $28.2M per year.(i)
  • Amylyx Pharmaceuticals's estimated revenue per employee is $108,084
  • Amylyx Pharmaceuticals's total funding is $202.2M.

Employee Data

  • Amylyx Pharmaceuticals has 261 Employees.(i)
  • Amylyx Pharmaceuticals grew their employee count by 61% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Amylyx Pharmaceuticals News

2022-03-30 - Here's Why Amylyx Pharmaceuticals Stock Is Getting ...

Shares of Amylyx Pharmaceuticals ( AMLX -8.81% ), a clinical-stage biopharmaceutical company, are tanking in response to comments from the...

2022-03-30 - Amylyx Stock Plummets as FDA Raises Doubts Over ALS Drug

Shares of Amylyx Pharmaceuticals lost more than half of their value after the Food and Drug Administration issued a skeptical analysis of...

2022-03-30 - Tracking the FDA advisory panel on Amylyx Pharma's ALS ...

... convening a meeting of outside experts today to review clinical data on an experimental treatment for ALS from Amylyx Pharmaceuticals.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding